Taj Mahal is a mausoleum built on Shiva temple: Vinay Katiyar

Agencies
October 18, 2017

Lucknow, Oct 18: Giving a new twist to the controversy surrounding the Taj Mahal, senior BJP leader Vinay Katiyar today said it was Lord Shiva's temple called 'Tejo Mahal' which was converted into a mausoleum by Shahjahan.

He, however, added that he does not want the monument as famous as this, which is among the wonders of the world, to be demolished.

He also has no objection to Chief Minister Yogi Adityanath visiting the Taj Mahal to review tourism schemes.

"It was Tejo Mahal, Lord Shiva's temple, where Shahjahan buried his wife and turned it into a mausoleum," said, Katiyar who had been in the forefront of the Ram temple movement of Ayodhya.

"It was constructed by Hindu kings, the rooms and carvings there prove that it was a Hindu monument... it has also been termed as one by historian PN Oak," he said about the Taj.

He said like a Shiva temple, water drips from the ceiling in the Taj Mahal, which is not a case in any mausoleum anywhere and is like that only on a Shivlinga. "It was a famous monument and was grabbed by Shahjahan," Katiyar said. "It was our temple but was made a mausoleum as they had more power. But it is a grand monument and national heritage... people come to see it and so it should be kept safe and secure," he said.

Katiyar, who is also an accused in the Babri case, said no political meaning should be derived from today's grand Diwali celebrations in Ayodhya by the Adityanath government.

"The aim is to develop Ayodhya...the effort is to recreate the scene of Lord Ram's return to Ayodhya from exile," Katiyar said, adding there is no politics behind the function as seen by the opposition. On the issue of Ram temple construction, Katiyar hoped that the court verdict will come in a year's time as the hearing is being conducted on a day-to-day basis.

"I hope some way will be found to construct Ram temple or else we can construct it on the lines of Somnath temple...We will look at the alternatives as options like dialogue or (constructing) on the lines of Somnath temple are open...but we want the temple," he said.

The stone carving work for the first storey is over and that of the second storey is on, he said, adding, "As soon as we get the land, we can start construction."

Comments

Wellwisher
 - 
Thursday, 19 Oct 2017

We salute on your knowledge and on  comments. Suggest to provide the instituion name where u and your groups trained.

 

Diwali Pataaka

Asiya
 - 
Thursday, 19 Oct 2017

take Taj Mahal, take Shahjahan Mumtaz or Salim we don't want them They are not our God or Taj Mahal is not Masjid. But, it is one of the wonders of the world and India getting fame (somehow, coz worldwide we are famous for communal riots) because of this at least India is getting money through tourist sector. So please someone educate these terrorist outfits.

PK
 - 
Wednesday, 18 Oct 2017

What about Job?What about Education?What about price rise?What about petrol hike?What about increasing prices for commodity?What about daily needs for the public? How long will U guys FOOL the public by taking only Fake history that has been taught to YOU in cheddi office... Wake up public

 

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
August 4,2020

New Delhi, Aug 4: India witnessed a single-day spike of 52,050 COVID-19 cases as the total cases in the country reached 18,55,746, the Union Ministry of Health and Family Welfare said on Tuesday.

803 COVID-19 related deaths were reported in the last 24 hours. The total cases include 5,86,298 active cases, 12,30,510 cured/discharged/migrated and 38,938 deaths, the Health Ministry added.

Maharashtra continues to be the worst-affected state as it has a total of 1,47,324 active cases and 15,842 deaths. A total of 4,50,196 coronavirus cases have been recorded in the state up to Monday, according to Union Ministry of Health.

Tamil Nadu reported 5,609 new COVID-19 cases and 109 deaths on Monday, taking total cases to 2,63,222 including 2,02,283 discharges and 4,241 deaths, the state Health Department said.

The total cases in Delhi have risen to 1,38,482 including 1,24,254 recovered/discharged/migrated cases and 4,021 deaths, according to the Ministry of Health.

Meanwhile, India recorded the highest single-day testing by conducting over 6.6 lakh tests to diagnose COVID-19 in the last 24 hours.
"In its fight against COVID-19, India scales a new high of 6,61,715 tests in the last 24 hours," said the Health Ministry in a tweet.

A total of 2,08,64,206 samples for COVID-19 have been tested across the country so far, said the Health Ministry.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 25,2020

New Delhi, Jun 25: After the Drug Controller General of India (DCGI) given its approval to manufacture and market the generic version of COVID-19 drug Remdesivir, COVIFOR, Hyderabad-based drugmaker Hetero Limited has delivered the first set of 20,000 vials in two equal lots of 10,000 each across 5 states.

The first batch, which is being marketed under the brand name of COVIFOR, was delivered to Maharashtra, Delhi, Gujarat Tamil Nadu and Hyderabad. Hetero has set a target to produce one lakh vials of the drug in two-three weeks.

The other lot would be supplied to Kolkata, Indore, Bhopal, Lucknow, Patna, Bhubaneshwar, Ranchi, Vijayawada, Cochin, Trivandrum and Goa within a week to meet the emergency requirements.

Managing director of Hetero Healthcare M Srinivasa Reddy said “the launch of Covifor in the country is a milestone in addressing public health emergencies. Through Covifor, we hope to reduce the treatment time of a patient in a hospital thereby reducing the increasing pressure on the medical infrastructure overburdened ue to accelerating COVID-19 infection rates," he said as reported by news agency.

"We are closely working with the government and the medical community to make Covifor quickly accessible to both public and private healthcare settings across the country”, Reddy said.

Covifor is a generic brand of Remdesivir which is used for the treatment of COVID-19 in adults and children hospitalised with strong symptoms of the disease. The Health Ministry had, on June 13, recommended the use of anti-viral drug Remdesivir in moderate stage of COVID-19.

Dr Reddys Laboratories and Hetero are among others which have separately entered into non-exclusive licensing agreements with the original drug-maker Gilead Sciences Inc to register, make and sell the investigational drug Remdesivir in India and other countries.

Remdesivir would be made in the company's formulation facility in Hyderabad, which has been approved by global regulatory authorities such as US Food and Drug Administration (USFDA) and EU, among others, Hetero had earlier said.

The treatment first showed improvement in trials on coronavirus patients and was approved for emergency use in severely ill patients in the United States and South Korea.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 24,2020

Kochi, Apr 24: The central government on Thursday submitted a statement in the Kerala High Court on the three petitions challenging the contract between Kerala government and US-based data analytics company Sprinklr.

Assistant Solicitor General P Vijayakumar filed the statement on behalf of the central government, which is the second respondent in the case.

The statement said that the contract between the Kerala government and Sprinklr dilutes the rights of the people. It stated the contract does not specify the amount of compensation that individuals should receive in case of breach of privacy or misuse of information.

It also said that it was not clear whether the information was collected and handed over to the data analytics firm with full consent of the patients (suspected and otherwise).

''It is always preferable to utilise the services available in the government sector for sharing sensitive data required for analytical purposes.

The Government of India has introduced the 'Aarogya Setu' application for collection of health data and about seven crore Indian citizens have already downloaded the same. All the state governments are advised to promote the said application for fighting the pandemic," the statement said.

It was further submitted that the "Government of India with the support of NIC is capable of providing all the requirements relating to data storage, processing and application which are being offered the third respondent, if a request to that effect comes from the state government."

Kerala Congress leader Ramesh Chennithala and BJP state president K Surendran had earlier approached the Kerala High Court seeking cancellation of the state government's agreement with Sprinklr for processing of data related to COVID-19 patients.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.